Reading by goal
Timelines, comparisons and how-to pieces, filed by what you are actually trying to do. Pick a goal to narrow the list. Everything here is written from published sources.
Reconstitution explained: how peptides go from powder to solution
mcg, mg and IU: peptide dosing units explained
Retatrutide vs tirzepatide: what the trials actually show
Retatrutide timeline: what research and user reports show in the first 8 weeks
Weeks 1 to 2 tend to bring the first appetite drop and mild GI adjustment. Each step up in dose commonly.
MOTS-C timeline: what research and user reports show in the first 4 weeks
The first week or so commonly brings a flat, low-energy stretch as AMPK activation resets how cells handle.
BPC-157 timeline: what research and user reports show over 8 weeks
Most controlled evidence on healing speed comes from animal models, not people, so any human timeline below.
Semaglutide timeline: what the published trials and research reports show
The published STEP 1 trial reported a mean 14.9 percent body weight reduction at 68 weeks on the 2.4 mg.
Tirzepatide timeline: what the published trials and research reports show
The SURMOUNT-1 trial reported average weight change of roughly 15, 19 and 21 percent at the 5, 10 and 15 mg.
Cagrilintide timeline: what the published trials and research reports show
In the REDEFINE 1 trial, cagrilintide alone produced a mean 11.5 percent body weight reduction at 68 weeks.
TB-500 timeline: what research and user reports show over 6 weeks
Most controlled evidence on TB-500 comes from animal models of systemic tissue repair, not human trials.
GHK-Cu timeline: what research and user reports show over 12 weeks
Most controlled evidence on GHK-Cu comes from topical skin studies rather than injectable human trials.
CJC-1295 and Ipamorelin timeline: what research and user reports show
Reports commonly describe a short flush or warmth at the injection site in the first days, deeper sleep.
Ipamorelin timeline: what research and user reports show
Ipamorelin is generally reported as the gentlest of the GH secretagogues, with mild injection-site effects in.
Tesamorelin timeline: what the published trials and research reports show
Tesamorelin has real controlled human trial data, mainly in visceral fat reduction, with published studies.
Sermorelin timeline: what research and user reports show
Sermorelin's human evidence is mainly historical, in diagnosing and treating childhood growth-hormone.
GHRP-6 timeline: what research and user reports show
GHRP-6 is one of the original growth-hormone releasing peptides, and it is also reported to stimulate.
Melanotan 1 timeline: what research and user reports show
Melanotan 1 is generally reported as producing fewer side effects than Melanotan 2, since it is more.
Melanotan 2 timeline: what research and user reports show
Melanotan 2 is broadly reported as producing more nausea and flushing than Melanotan 1, since it is less.
PT-141 timeline: what to expect per dose, not per week
Unlike most peptides on this site, PT-141 is generally reported as an acute, per-dose compound rather than.
Semax timeline: what research and user reports show
Semax is generally reported to work faster than most peptides on this site, with cognitive effects commonly.
Selank timeline: what research and user reports show
Selank is generally reported to produce a calming effect within the same day of use, with cumulative.
NAD+ timeline: what research and user reports show
NAD+ reports vary sharply by route. Faster infusion or high subcutaneous doses are commonly associated with.
AOD-9604 timeline: what the research actually shows
AOD-9604 was studied in human obesity trials that were ultimately discontinued due to insufficient efficacy.
Thymosin Alpha-1 timeline: what research and user reports show
Thymosin Alpha-1 is approved in several countries as an immune modulator. Reports describe it being used in.
KPV timeline: what research and user reports show
KPV is studied mainly for anti-inflammatory effects in gut and skin contexts. Reports describe early changes.
Gonadorelin timeline: what research and user reports show
Gonadorelin is generally used as an ancillary compound alongside other hormone protocols rather than alone.
DSIP timeline: what research and user reports show
DSIP is studied for its link to slow-wave sleep. Reports commonly describe an effect on sleep quality the.
Epithalon timeline: what research and user reports show
Epithalon is typically studied and used in short courses rather than continuously. Reports describe sleep and.
Glutathione timeline: what research and user reports show
Glutathione is the body's main intracellular antioxidant. Reports describe early changes in energy or skin.
Dihexa timeline: what research and user reports show
Dihexa is a newer research compound with limited human data. Reports of cognitive changes, where they exist.
Oxytocin timeline: what to expect per dose, not per week
Oxytocin's research effects are generally reported within an hour of a dose, tied to social bonding and.
SS-31 timeline: what research and user reports show
SS-31, studied clinically as elamipretide, concentrates in mitochondria similar to MOTS-C's pathway. Reports.
GLOW blend timeline: what research and user reports show
GLOW combines GHK-Cu, BPC-157 and TB-500, so its reported timeline is really the overlap of three separate.
KLOW blend timeline: what research and user reports show
KLOW is GLOW with KPV added, combining an anti-inflammatory tripeptide with the skin-and-repair GLOW.
Wolverine blend timeline: what research and user reports show
The Wolverine blend pairs BPC-157 and TB-500, the two most-discussed repair peptides. Its reported timeline.
Reconstitution in one worked example
Semaglutide vs Tirzepatide
Evidence grade, schedule, half-life and cost side by side.
Retatrutide vs Semaglutide
Evidence grade, schedule, half-life and cost side by side.
BPC-157 vs TB-500
Evidence grade, schedule, half-life and cost side by side.
Ipamorelin vs Sermorelin
Evidence grade, schedule, half-life and cost side by side.
Tesamorelin vs Sermorelin
Evidence grade, schedule, half-life and cost side by side.
Cagrilintide vs Semaglutide
Evidence grade, schedule, half-life and cost side by side.
Semax vs Selank
Evidence grade, schedule, half-life and cost side by side.
Melanotan 1 vs Melanotan 2
Evidence grade, schedule, half-life and cost side by side.